START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
MedPage Today on MSN
Hold GLP-1s before endoscopy? Clinical trial finds retained gastric contents
Residual gastric volume precluded endoscopic examination ...
Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company developing carbohydrate-based therapeutics, today announced results from a randomized, double-blind, placebo-controlled Phase 1b/2a ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...
Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...
Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...
UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
The British Pharmacological Society has called for clearer, evidence-based guidance on medication use during pregnancy and ...
Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results